Custom High Throughput Sequencing (HTS)

A variety of test methods - biological, serological, biochemical and molecular - are used currently in plant diagnostics and each has advantages and disadvantages. Classic diagnostic methods require prior knowledge of the pathogen in question and in some cases, require 2-4 years to complete. High throughput sequencing (HTS), also known as next generation sequencing (NGS), is a new, efficient method for obtaining nucleic acid sequences.

What is high throughput sequencing?

HTS provides the nucleic acid sequences in a sample which are compared with sequences known to be common to pathogens. For example, a motif or signature sequence in the family Geminiviridae is a unifying feature that, along with other identifying features, can place other viruses within the same family. Further analysis will determine if this virus is a known or a novel virus. by using this principle of conserved sequences between related pathogens.

How is it done?

There are many variations of HTS sequencing platforms and different nucleic acid templates, such as small RNA, double-stranded RNA, or total nucleic acid can be used. Amplifying and sequencing purified DNA occurs when DNA molecules are attached to a chip and the sequencer reads millions of sequences per run. ‘Reads’ are built one nucleotide base at a time during the sequencing operation. One HTS run takes about one day and can produce hundreds of millions of reads. This large-scale simultaneous synthesis of reads is what makes the process high throughput.

What are the benefits of HTS?

HTS is rapid, accurate, and efficient in the detection and identification of viral pathogens. It provides a comprehensive picture of the entire microbial profile of a sample. In studies comparing the efficacy of HTS and conventional assays used to detect grapevine and fruit tree viruses, researchers found that HTS was superior in its ability to detect viruses of economic significance (including low titer viruses), comprehensiveness, speed of analysis, and ability to discover novel, uncharacterized viruses.

What are the limitations of HTS?

While HTS remains a powerful new technology with significant benefits, there are challenges associated with the technology. Due to its sensitivity, microbes of unknown pathogenicity are detected. Detection of a given microbe does not mean that it is responsible for disease. It is essential to establish biological significance to determine if the microbes sequenced are indeed biologically important. Biological significance is assessed by performing graft transmission, fulfilling Koch’s postulates, analyzing spread and distribution, and assessing economic significance of symptoms.

No detection methodology is perfect. HTS and bioinformatics tools are only as good as the reference databases used. For example, novel virus sequences may be quite different from those deposited in databases. However, new methods that do not depend on sequence similarity are being explored and as knowledge expands so will the ability to identify novel species. In addition, efforts are underway to standardize HTS methodology across laboratories.